Moderna Affirms FY2026 Sales Guidance of $2.138B vs $2.089B Est
Moderna (NASDAQ: MRNA ) affirms FY2026 sales outlook from $2.138 billion to $2.138 billion vs $2.089 billion estimate.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Moderna (NASDAQ: MRNA ) affirms FY2026 sales outlook from $2.138 billion to $2.138 billion vs $2.089 billion estimate.